SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-072740
Filing Date
2020-06-12
Accepted
2020-06-12 11:47:12
Documents
2
Period of Report
2020-06-08

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 1629
2 EX-24 ex-24.htm EX-24 8652
  Complete submission text file 0001104659-20-072740.txt   11660
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Issuer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE MAIN STREET, SUITE 800 CAMBRIDGE MA 02142
Business Address
Harshbarger Benjamin (Reporting) CIK: 0001653133 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37467 | Film No.: 20959469